Intuitive Surgical da Vinci Xi vs CMR Surgical Versius

Intuitive Surgical da Vinci Xi

The Intuitive Surgical da Vinci Xi is the world's most widely deployed robotic-assisted surgical system, enabling surgeons to perform complex minimally invasive procedures across multiple abdominal quadrants through four overhead-mounted robotic arms with EndoWrist instruments offering seven degrees of freedom. Featuring 3D HD visualisation at 10x magnification and motion scaling that eliminates hand tremor, the da Vinci Xi is FDA-cleared for general surgery, urology, gynaecology, thoracic, and cardiac procedures. With over 7,000 systems installed globally and more than 10 million procedures performed, it is the dominant robotic surgery platform worldwide. Hospital acquisition cost ranges from $1.5M to $2.5M with annual service contracts and per-procedure instrument costs of $700–$3,500.

CMR Surgical Versius

The CMR Surgical Versius is a modular robotic-assisted surgical system where each robotic arm is a separate portable tower that can be wheeled between operating rooms and reconfigured for different minimally invasive procedures — general, colorectal, gynaecological, and urological surgery. With three independent arm units each offering seven degrees of freedom and 3D HD visualisation, Versius is CE marked and FDA cleared for abdominal and pelvic surgery. Developed in Cambridge, UK, Versius was designed to make robotic surgery accessible to more hospitals by reducing the fixed capital cost per operating room compared to monolithic systems. It is deployed across hospitals in Europe, Asia-Pacific, and the US. Pricing is available through usage-based and purchase contracts from CMR Surgical.